Multiple Assemblies exist for SMTL entry 3v9b
Crystal structure of the catalytic domain of PDE4D2 with (S)-N-(3-{1-[1-(3-Cyclopropylmethoxy-4-difluoromethoxyphenyl)-2-(1-oxypyridin-4-yl)-ethyl]-1H-pyrazl-3-yl}phenyl)acetamide; X-RAY DIFFRACTION 2.10 Å

SMTL ID
3v9b.1
Ligands
N-(3-{1-[(1S)-1-[3-(CYCLOPROPYLMETHOXY)-4-(DIFLUOROMETHOXY)PHENYL]-2-(1-OXIDOPYRIDIN-4-YL)ETHYL]-1H-PYRAZOL-3-YL}PHENYL)ACETAMIDE; ZINC ION
Polypeptides
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
Oligo-state
monomer
SMTL ID
3v9b.2
Ligands
N-(3-{1-[(1S)-1-[3-(CYCLOPROPYLMETHOXY)-4-(DIFLUOROMETHOXY)PHENYL]-2-(1-OXIDOPYRIDIN-4-YL)ETHYL]-1H-PYRAZOL-3-YL}PHENYL)ACETAMIDE; ZINC ION
Polypeptides
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
Oligo-state
monomer
SMTL ID
3v9b.3
Ligands
N-(3-{1-[(1S)-1-[3-(CYCLOPROPYLMETHOXY)-4-(DIFLUOROMETHOXY)PHENYL]-2-(1-OXIDOPYRIDIN-4-YL)ETHYL]-1H-PYRAZOL-3-YL}PHENYL)ACETAMIDE; ZINC ION
Polypeptides
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
Oligo-state
monomer
SMTL ID
3v9b.4
Ligands
N-(3-{1-[(1S)-1-[3-(CYCLOPROPYLMETHOXY)-4-(DIFLUOROMETHOXY)PHENYL]-2-(1-OXIDOPYRIDIN-4-YL)ETHYL]-1H-PYRAZOL-3-YL}PHENYL)ACETAMIDE; ZINC ION
Polypeptides
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
Oligo-state
monomer